539 related articles for article (PubMed ID: 27995696)
21. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
[TBL] [Abstract][Full Text] [Related]
22. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
23. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
24. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
[TBL] [Abstract][Full Text] [Related]
25. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
[TBL] [Abstract][Full Text] [Related]
27. CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload-Induced Heart Failure.
Richards DA; Aronovitz MJ; Liu P; Martin GL; Tam K; Pande S; Karas RH; Bloomfield DM; Mendelsohn ME; Blanton RM
Circ Heart Fail; 2021 Jan; 14(1):e007300. PubMed ID: 33464954
[TBL] [Abstract][Full Text] [Related]
28. Possible retinotoxicity of long-term vardenafil treatment.
Szabó K; Dékány B; Énzsöly A; Hajdú RI; Laurik-Feuerstein LK; Szabó A; Radovits T; Mátyás C; Oláh A; Kovács KA; Szél Á; Somfai GM; Lukáts Á
Exp Eye Res; 2024 Jun; 243():109890. PubMed ID: 38615833
[TBL] [Abstract][Full Text] [Related]
29. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
[TBL] [Abstract][Full Text] [Related]
30. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
31. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
Fukuhara S; Tsujimura A; Okuda H; Yamamoto K; Takao T; Miyagawa Y; Nonomura N; Okuyama A
J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
[TBL] [Abstract][Full Text] [Related]
32. Changes in Left Ventricular Ejection Fraction and Oxidative Stress after Phosphodiesterase Type-5 Inhibitor Treatment in an Experimental Model of Retrograde Rat Perfusion.
Krivokapic M; Alisultanovich Omarov I; Zivkovic V; Nikolic Turnic T; Jakovljevic V
Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984459
[No Abstract] [Full Text] [Related]
33. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
[TBL] [Abstract][Full Text] [Related]
34. Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Xue M; Li T; Wang Y; Chang Y; Cheng Y; Lu Y; Liu X; Xu L; Li X; Yu X; Sun B; Chen L
Clin Sci (Lond); 2019 Aug; 133(15):1705-1720. PubMed ID: 31337673
[TBL] [Abstract][Full Text] [Related]
35. Right-ventricular dysfunction in HFpEF is linked to altered cardiomyocyte Ca
Hegemann N; Primessnig U; Bode D; Wakula P; Beindorff N; Klopfleisch R; Michalick L; Grune J; Hohendanner F; Messroghli D; Pieske B; Kuebler WM; Heinzel FR
ESC Heart Fail; 2021 Aug; 8(4):3130-3144. PubMed ID: 34002482
[TBL] [Abstract][Full Text] [Related]
36. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes.
Feng B; Yu P; Yu H; Qian B; Li Y; Sun K; Shi B; Zhang N; Xu G
Diabetol Metab Syndr; 2023 Jun; 15(1):141. PubMed ID: 37386620
[TBL] [Abstract][Full Text] [Related]
38. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
[TBL] [Abstract][Full Text] [Related]
39. OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction.
van der Pol A; Gil A; Tromp J; Silljé HHW; van Veldhuisen DJ; Voors AA; Hoendermis ES; Grote Beverborg N; Schouten EM; de Boer RA; Bischoff R; van der Meer P
Cardiovasc Res; 2018 Dec; 114(14):1871-1882. PubMed ID: 30032247
[TBL] [Abstract][Full Text] [Related]
40. Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trial.
Scheffer M; Driessen-Waaijer A; Hamdani N; Landzaat JWD; Jonkman NH; Paulus WJ; van Heerebeek L
ESC Heart Fail; 2020 Dec; 7(6):4478-4487. PubMed ID: 33073523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
